Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("PRICE, K. N")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 29

  • Page / 2
Export

Selection :

  • and

Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancerGRUBER, G; COLE, B. F; FEV, M. F et al.Annals of oncology. 2008, Vol 19, Num 8, pp 1393-1401, issn 0923-7534, 9 p.Article

Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trialMAURIAC, L; KESHAVIAH, A; NOGARET, J.-M et al.Annals of oncology. 2007, Vol 18, Num 5, pp 859-867, issn 0923-7534, 9 p.Article

Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancerVIALE, G; GIOBBIE-HURDER, A; PRICE, K. N et al.Annals of oncology. 2010, Vol 21, Num 2, pp 245-254, issn 0923-7534, 10 p.Article

Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experienceBERCLAZ, G; LI, S; SNYDER, R et al.Annals of oncology. 2004, Vol 15, Num 6, pp 875-884, issn 0923-7534, 10 p.Article

Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer : The International Breast Cancer Study Group Trial VIICRIVELLARI, D; BONETTI, M; LINDTNER, J et al.Journal of clinical oncology. 2000, Vol 18, Num 7, pp 1412-1422, issn 0732-183XArticle

Premenopausal endocrine-responsive early breast cancer : who receives chemotherapy?REGAN, M. M; PAGANI, O; CASTIGLIONE-GERTSCH, M et al.Annals of oncology. 2008, Vol 19, Num 7, pp 1231-1241, issn 0923-7534, 11 p.Article

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)PESTALOZZI, B. C; ZAHRIEH, D; SIMONCINI, E et al.Annals of oncology. 2006, Vol 17, Num 6, pp 935-944, issn 0923-7534, 10 p.Article

Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer : role of endocrine responsiveness of the tumorCOLLEONI, M; LI, S; PAGANI, O et al.Annals of oncology. 2005, Vol 16, Num 5, pp 716-725, issn 0923-7534, 10 p.Article

Routine tests during follow-up of patients after primary treatment for operable breast cancerCRIVELLARI, D; PRICE, K. N; CORTES-FUNES, H et al.Annals of oncology. 1995, Vol 6, Num 8, pp 769-776, issn 0923-7534Article

Prognostic importance of c-erbB-2 expression in breast cancerGUSTERON, B. A; GELBER, R. D; MARTINEZ-TELLO, F et al.Journal of clinical oncology. 1992, Vol 10, Num 7, pp 1049-1056, issn 0732-183XArticle

Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trialsHUOBER, J; GELBER, S; GOLDHIRSCH, A et al.Annals of oncology. 2012, Vol 23, Num 11, pp 2843-2851, issn 0923-7534, 9 p.Article

Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancerBERNHARD, J; ZAHRIEH, D; GREEN, M. D et al.British journal of cancer. 2008, Vol 98, Num 1, pp 25-33, issn 0007-0920, 9 p.Article

Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracilCOLLEONI, M; PRICE, K. N; CASTIGLIONE-GERTSCH, M et al.Lancet (British edition). 1999, Vol 354, Num 9173, pp 130-131, issn 0140-6736Article

The effect of adjuvant prednisone combined with CMF on patterns of relapse and occurrence of second malignancies in patients with breast cancerMARINI, G; MURRAY, S; CAVALLI, F et al.Annals of oncology. 1996, Vol 7, Num 3, pp 245-250, issn 0923-7534Article

Factors predicting treatment responsiveness and prognosis in node-negative breast cancerNEVILLE, A. M; BETTELHEIM, R; ISLEY, M et al.Journal of clinical oncology. 1992, Vol 10, Num 5, pp 696-705, issn 0732-183XArticle

Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancerRIBI, K; ALDRIDGE, J; PRICE, K. N et al.British journal of cancer. 2012, Vol 106, Num 10, pp 1618-1625, issn 0007-0920, 8 p.Article

The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-upCOLLEONI, M; SUN, Z; VIALE, G et al.Annals of oncology. 2009, Vol 20, Num 8, pp 1344-1351, issn 0923-7534, 8 p.Article

CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence : a combined analysis of seven International Breast Cancer Study Group trialsKESHAVIAH, A; DELLAPASQUA, S; PRICE, K. N et al.Annals of oncology. 2007, Vol 18, Num 4, pp 701-708, issn 0923-7534, 8 p.Article

Effect of systemic adjuvant treatment on first sites of breast cancer relapseGOLDHIRSCH, A; GELBER, R. D; BYRNE, M et al.Lancet (British edition). 1994, Vol 343, Num 8894, pp 377-381, issn 0140-6736Article

Present and future projects of the International Breast Cancer Study GroupGOLDHIRSCH, A; GELBER, R. D; CAVALLI, F et al.Cancer. 1994, Vol 74, Num 3, pp 1139-1149, issn 0008-543X, SUPConference Paper

Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group reportKARLSSON, P; COLE, B. F; FORBES, J. F et al.Annals of oncology. 2012, Vol 23, Num 11, pp 2852-2858, issn 0923-7534, 7 p.Article

Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trialEJLERTSEN, B; ALDRIDGE, J; VIALE, G et al.Annals of oncology. 2012, Vol 23, Num 5, pp 1138-1144, issn 0923-7534, 7 p.Article

Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IXAEBI, S; SUN, Z; KARLSSON, P et al.Annals of oncology. 2011, Vol 22, Num 9, pp 1981-1987, issn 0923-7534, 7 p.Article

Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancerKARLSSON, P; SUN, Z; ZAMAN, K et al.Annals of oncology. 2011, Vol 22, Num 10, pp 2216-2226, issn 0923-7534, 11 p.Article

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trialVIALE, G; REGAN, M. M; LANG, I et al.Annals of oncology. 2011, Vol 22, Num 10, pp 2201-2207, issn 0923-7534, 7 p.Article

  • Page / 2